Health TrialsbyHealthPanel

The Efficacy of Online Exergaming-Integrated Physiotherapy for Parkinson's Disease

ConditionParkinsonism in Diseases Classified Elsewhere
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-90
SponsorChang Gung Memorial Hospital

About this trial

To validate the efficiency of online exergaming-based physiotherapy. We will enroll patients with Parkinson's disease in postural instability and gait disturbance motor phenotype in the study and divide them into two groups in a randomized controlled study.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

Moderate and severe dementia (Clinical Dementia Rating more than or equal to 2)

Advanced PD stage (Hoehn and Yahr staging equal or more than four)

Trial design

Design model

Parallel

Treatments tested in this trial

  • online exergaming-based physiotherapy programs

    Other intervention

    The online exergaming-based physiotherapy programs focus on training in shoulder, hip, and knee ROM balance, weight-bearing, strength, weight shifting, and walking based on RF in machine learning to the features selection in patients with PIGD. The training tasks consist of a set of 10 pieces of training (20 min per session, five sessions every week, for 8 weeks). Five exergaming programs were used for training, designed to incorporate an appropriate level of challenge to match the ability and fitness of patients with PD.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Online exergaming-based physiotherapy intervention groupExperimental treatment 1 intervention
Group B: Online exergaming-based physiotherapy observation groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Unified Parkinson's Disease Rating Scale score assessment

The outcome measure is the Unified Parkinson's Disease Rating Scale score. The UPDRS scale consists of the following six segments: 1) Mentation, Behavior, and Mood, 2) ADL, 3) Motor sections, and 4) Complications of Therapy (in the past week) The four segments are made up of 42 items grouped into four subscales. Each item has 0-4 ratings: 0 (normal), 1 (slight), 2 (mild), 3 (moderate), and 4 (severe)

Time frame
Intervention and follow-up period through study completion, an average of 3 years
2

Tinetti balance and gait score assessment

The score consists of two parts, including the balance score (score=0-16) and gait score (score=0-12), and ranged from 0 to 28 points by summing the points obtained for each of the two tests.

Time frame
Intervention and follow-up period through study completion, an average of 3 years

Secondary outcomes

1

Fall Risk assessment using Berg Balance Scale

The maximum obtainable Berg Balance Scale is 56 and there are four ranges of scores. Patients scoring range of 41-56, 21-40, and 0 -20 indicate low fall risk, medium fall risk, and high fall risk, respectively

Time frame
intervention and follow-up period through study completion, an average of 3 years
2

Depression severity assessment

To obtain a patient-based measurement of depression, the Geriatric Depression Scale (GDS-30) was used. Depression severity was classified using the GDS-30 as follows: No depression (GDS 0-9), mild depression (GDS 10-19), and severe depression (GDS 20-30).

Time frame
intervention and follow-up period through study completion, an average of 3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chang Gung Memorial Hospital

Lead sponsor

National Science and Technology Council

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: